Search results
Showing 2656 to 2670 of 8933 results
Awaiting development Reference number: GID-TA11975 Expected publication date: TBC
Awaiting development Reference number: GID-TA11976 Expected publication date: TBC
Tarlatamab for maintenance treatment of extensive-stage small-cell lung cancer [TSID12358]
Awaiting development Reference number: GID-TA11977 Expected publication date: TBC
In development Reference number: GID-TA11817 Expected publication date: 09 July 2026
Awaiting development Reference number: GID-TA11919 Expected publication date: TBC
In development Reference number: GID-TA11694 Expected publication date: TBC
In development Reference number: GID-TA11566 Expected publication date: 10 June 2026
Nivolumab with ipilimumab for untreated advanced hepatocellular carcinoma [ID6239]
In development Reference number: GID-TA11116 Expected publication date: 11 November 2026
Awaiting development Reference number: GID-TA11978 Expected publication date: TBC
Summary of the evidence on infliximab for treating pulmonary sarcoidosis to inform local NHS planning and decision-making
Antimicrobial prescribing: meropenem with vaborbactam (ES21)
Summary of the evidence on antimicrobial prescribing of meropenem with vaborbactam (Vaborem) to inform local NHS planning and decision making
Summary of the evidence on the antimicrobial prescribing of ceftolozane with tazobactam for hospital-acquired pneumonia, including ventilator-associated
Remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis (ES29)
Summary of the evidence on remsima (infliximab biosimilar) for subcutaneous injection for managing rheumatoid arthritis
Antimicrobial prescribing: imipenem with cilastatin and relebactam (ES30)
Summary of the evidence on antimicrobial prescribing: imipenem with cilastatin and relebactam
Summary of the evidence on antimicrobial prescribing: delafloxacin